Archive > October 2009

Eli Lilly Settles Zyprexa Suit With South Carolina

admin » 26 October 2009 » In Defective Products, Mass Tort » No Comments

Eli Lilly Settles Zyprexa Suit With South Carolina

South Carolina’s attorney general, Henry McMaster, said the state had reached a $45 million settlement with the drug maker Eli Lilly & Company over the company’s marketing of an antipsychotic drug. Mr. McMaster’s office said Friday that the agreement was the second-largest settlement deal in state history. He sued Lilly, which is based in Indiana, in 2007, arguing that it had improperly marketed the drug, Zyprexa. The settlement recovers state money used to treat illnesses said to have been caused by the drug. In October 2008, Lilly reached a $62 million settlement with 32 states that had sued over Zyprexa. Lilly officials did not immediately answer a message on Friday.

Source

Continue reading...

Tags:

Relenza: FDA and Glaxo warn of death with anti-flu drug

admin » 19 October 2009 » In Defective Products » No Comments

Relenza: FDA and Glaxo warn of death with anti-flu drug

GlaxoSmithKline has notified doctors of at least one death caused by a inappropriate use of its anti-flu medication Relenza.

In a letter sent Thursday to doctors, Glaxo said the death resulted after the drug was reformulated into a liquid form, something not recommended by the Food and Drug Administration. The agency posted the letter online Friday. It did not provide details on the person who died.

Relenza comes in powder form for use with Glaxo’s Diskhaler device. The drug is approved to treat symptoms of the seasonal flu when taken within two days of onset.

FDA and London-based Glaxo stressed the safety of reconstituting Relenza has not been established.
The U.S. has stockpiled millions of doses of Relenza and Roche ( RHHBY.PK – news – people )’s Tamiflu.

Continue reading...

Insurers dropping Chinese drywall policies

admin » 15 October 2009 » In Defective Products » No Comments

Chinese Drywall

Insurers dropping Chinese drywall policies

James and Maria Ivory’s dreams of a relaxing retirement on Florida’s Gulf Coast were put on hold when they discovered their new home had been built with Chinese drywall that emits sulfuric fumes and corrodes pipes. It got worse when they asked their insurer for help — and not only was their claim denied, but they’ve been told their entire policy won’t be renewed.

Thousands of homeowners nationwide who bought new houses constructed from the defective building materials are finding their hopes dashed, their lives in limbo. And experts warn that cases like the Ivorys’, in which insurers drop policies or send notices of non-renewal based on the presence of the Chinese drywall, will become rampant as insurance companies process the hundreds of claims currently in the pipeline.

At least three insurers have already canceled or refused to renew policies after homeowners sought their help replacing the bad wallboard. Because mortgage companies require homeowners to insure their properties, they are then at risk of foreclosure, yet no law prevents the cancellations.

“This is like the small wave that’s out on the horizon that’s going to continue to grow and grow until it becomes a tsunami,” said Florida attorney David Durkee, who represents hundreds of homeowners who are suing builders, suppliers and manufacturers over the drywall. “This is going to become critical mass very shortly.”

During the height of the U.S. housing boom, with building materials in short supply, American construction companies imported millions of pounds of Chinese-made drywall because it was abundant and cheap. An Associated Press analysis of shipping records found that more than 500 million pounds of Chinese gypsum board was imported between 2004 and 2008 — enough to have built tens of thousands of homes. They are heavily concentrated in the Southeast, especially Florida.

Continue

Continue reading...

Tags:

Health Concerns Over Yaz

admin » 01 October 2009 » In Defective Products, Mass Tort » No Comments

Health Concerns Over Yaz

The oral contraceptives Yaz and Yasmin are the top-selling pharmaceutical line for Bayer HealthCare, largely as a result of marketing that presents them as much more than mere pregnancy prevention.

Yaz, in particular, the top-selling birth control pill in the United States, owes much of its popularity to multimillion-dollar ad campaigns that have promoted the drug as a quality-of-life treatment to combat acne and severe premenstrual depression.

Yaz, a newer sister drug to Yasmin, contains less estrogen. The franchise had worldwide sales of about $1.8 billion last year, based on Bayer’s successful positioning of Yasmin and Yaz as the go-to drug brands for women under 35.

But recently, the Yaz line’s image has been clouded by concerns from some researchers, health advocates and plaintiffs’ lawyers. They say that the drugs put women at higher risk for blood clots, strokes and other health problems than some other birth control pills do.

Continue Reading

Continue reading...

Tags: , ,

Google Wave

admin » 01 October 2009 » In Google » No Comments

Google Wave

The much awaited release of Google Wave is now taking place; with 100,000 lucky users getting invites to use the ambitious online communication and collaboration platform. Wave was first unveiled at Google I/O back in May, with Google co-founder Sergey Brin telling us that the product “will set a new benchmark for interactivity.” Our very own MG Siegler appeared yesterday on G4’s Attack of the Show to explain what’s so special about Wave and how it could change the web.


Source

Continue reading...

Tags: ,